Polycyclic pyrazines as potassium ion channel modulators

Details for Australian Patent Application No. 2005252160 (hide)

Owner Astellas Pharma Inc. Icagen, Inc.

Inventors Fulp, Alan Bradley; Seconi, Darrick; Ishii, Takahiro; Wang, Xiaodong; Suzuki, Takeshi; Spear, Kerry Leigh; Moritomo, Ayako

Agent Spruson & Ferguson

Pub. Number AU-A-2005252160

PCT Pub. Number WO2005/121126

Priority 60/562,149 13.04.04 US

Filing date 13 April 2005

Wipo publication date 22 December 2005

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/121126 Priority application(s): WO2005/121126

23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005252161-Color stable multilayer articles

2005252156-Improved interior contour for bore of friction support bearing of a railway locomotive traction motor